The Effect of Ovarian Stimulation on Endothelial Function-A Prospective Cohort Study using Peripheral Artery Tonometry.
Adult
Arteries
/ drug effects
Chorionic Gonadotropin
/ pharmacology
Cohort Studies
Endothelium, Vascular
/ drug effects
Female
Fertility Agents, Female
/ pharmacology
Fertilization in Vitro
Gonadotropin-Releasing Hormone
/ pharmacology
Humans
Hyperemia
/ chemically induced
Infertility
/ therapy
Manometry
Ovulation Induction
/ adverse effects
Pregnancy
EndoPAT
GnRH agonist
OHSS
endothelial function
hCG
triggering final follicular maturation
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
01 12 2020
01 12 2020
Historique:
received:
31
05
2020
accepted:
19
09
2020
pubmed:
25
9
2020
medline:
27
2
2021
entrez:
24
9
2020
Statut:
ppublish
Résumé
Gonadotropin-releasing hormone agonist (GnRH-a) serves as an alternative to human chorionic gonadotropin (hCG) to trigger final oocyte maturation, while it significantly reduces the risk of ovarian hyperstimulation syndrome (OHSS), probably by attenuating vascular/endothelial activation. The objectives of this work are to compare the effect of different modes of final follicular maturation (hCG vs GnRH-a) following ovarian stimulation (OS) for in vitro fertilization (IVF) on endothelial function. A prospective cohort study was conducted at a tertiary medical center. Patients age 37 years or younger, undergoing OS for IVF, were allocated into 2 groups according to the type of final follicle maturation: the hCG group (n = 7) or the GnRH-a group (n = 8). Endothelial function was assessed by measurement of the peripheral arterial tonometry in reaction to temporary ischemia at 3 study points: day 3 of menstrual cycle (day 0), day of hCG/GnRH-a administration (day trigger) and day of oocyte pick-up (day OPU). The ratio of arterial tonometry readings before and after ischemia is called the reactive hyperemia index (RHI). Decreased RHI (< 1.67) indicates endothelial dysfunction. The main outcomes measures of this study included endothelial function at 3 study points during OS with different modes of triggering final follicular maturation. The mean RHI values at day 0 were within the normal range for all patients and comparable between both groups (hCG: 1.7 ± 0.3 vs GnRH-a: 1.79 ± 0.4, P = .6). All patients presented a decrease in RHI values on day trigger, which did not differ between the 2 groups (1.62 ± 0.3 vs 1.4 ± 0.2, respectively, P = .2). However, the hCG group demonstrated a further decrease in RHI on day OPU, whereas patients who received GnRH-a had restored normal endothelial function reflected by increased RHI values (1.4 ± 0.2 vs 1.75 ± 0.2, respectively, P = .03). Triggering final follicular maturation with GnRH-a restored normal endothelial function, whereas hCG trigger resulted in a decrease in endothelial function.
Identifiants
pubmed: 32968793
pii: 5910711
doi: 10.1210/clinem/dgaa681
pii:
doi:
Substances chimiques
Chorionic Gonadotropin
0
Fertility Agents, Female
0
Gonadotropin-Releasing Hormone
33515-09-2
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.